Journals / Androloji Bülteni / 2020 / Cilt: 22 - Sayı: 1

Organ preserving surgery with ultrasound-guided marking in 4 mm testicular tumor

4 mm’lik testis tümörüne ultrason eşliğinde işaretleme ile organ koruyucu cerrahi

Pages
63–67
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our aim was to share the partial orchiectomy case which had a quite small testicular tumor with a diameter of 4 mm and the technique we used for this case.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Testicular cancer is the most common malignity seen in males between the ages of 15 and 45.
📊
Key Findings & Data:There has been an increase in the diagnosis of small asymptomatic testicular masses with extensive ultrasound use.
💡
Conclusion & Impact:Our aim was to share the partial orchiectomy case which had a quite small testicular tumor with a diameter of 4 mm and the technique we used for this case.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Testicular cancer is the most common malignity seen in males between the ages of 15 and 45. There has been an increase in the diagnosis of small asymptomatic testicular masses with extensive ultrasound use. Although radical orchiectomy is the standard treatment for testicular cancer, the importance of testicle preserving surgery has increased in recent years due to its promising oncological and functional results in the treatment of bilateral testicle cancer and small testicular masses. Testicle preserving treatment is suggested for testicular masses smaller than 2 cm in suitable patients. But small mass size makes the detectability and excision harder during the surgery. In literature, there are limited publications demonstrating organ preserving technique especially for small testicular tumors. Our aim was to share the partial orchiectomy case which had a quite small testicular tumor with a diameter of 4 mm and the technique we used for this case.

Özet

Testis kanseri 15–45 yaş arası erkeklerde en sık görülen malignitedir. Ultrasonun yaygın kullanımıyla birlikte küçük asemptomatik testisküler kitlelerin tanısında da artış olmuştur. Radikal orşiektomi testis kanserinin standart tedavisi olmasına karşın; son yıllarda bilateral testis kanseri ve küçük testiküler kitlelerin tedavisinde umut verici onkolojik ve fonksiyonel sonuçları nedeniyle testis koruyucu cerrahinin yeri artmıştır. 2 cm’den küçük testis kitlelerinde uygun hastalara testis koruyucu tedavi yapılabilmesi önerilmektedir. Fakat kitlenin küçük olması cerrahi sırasında bulunabilirliği ve eksizyonu zorlaştırmaktadır. Literatürde özellikle küçük testis tümörleri için organ koruyucu tekniği gösteren az sayıda yayın vardır. Bizde 4 mm çaplı oldukça küçük testis tümörü olan hasta da yaptığımız parsiyel orşiektomi olgusunu ve kullandığımız tekniği paylaşmak istedik.

🔖

Cite This Article

TAŞKAPU, H. H., SÖNMEZ, M. G., ECER, G., KILINÇ, M. T., BATDIK, S., ÖZTÜRK, A. (2020). Organ preserving surgery with ultrasound-guided marking in 4 mm testicular tumor. Androloji Bülteni, Cilt: 22 - Sayı: 1, 63–67. https://ajindex.com/articles/141484

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Manecksha RP, Fitzpatrick JM. Epidemiology of testicular cancer. BJU Int 2009
  2. 1329–33. [CrossRef] 2. Dieckmann KP, Frey U, G Lock. Contemporary diagnostic workup of testicular germ cell tumours. Nat Rev Urol 2013
  3. 703–12. [CrossRef] 3. Carmignani L, Gadda F, Gazzano G, Nerva F, Mancini M, Ferruti M, et al. High incidence of benign testicular neoplasm diagnosed by ultrasound. J Urol 2003
  4. 1783–86. [CrossRef] 4. Bumbasirevic U, Bojanic N, Pekmezovic T, Janjic A, Janicic A, Milojevic B, Tulic C. Health-related quality of life, depression, and sexual function in testicular cancer survivors in a developing country: A Serbian experience. Support Care Cancer 2013
  5. 757–63. [CrossRef] 5. Giannarini G, Dieckmann KP, Albers P, Heidenreich A, Pizzocaro G. Organ-sparing surgery for adult testicular tumours: A systematic review of the literature. Eur Urol 2010
  6. 780–90. [CrossRef] 6. Borghesi M, Brunocilla E, Schiavina R, Gentile G, Dababneh H, Della Mora L, et al. Role of testis sparing surgery in the conservative management of small testicular masses: Oncological and functional perspectives. Actas Urol Esp 2015
  7. 57–62. [CrossRef] 7. Lawrentschuk N, Zuniga A, Grabowksi AC, Rendon RA, Jewett MA. Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: A large North American experience. J Urol 2011
  8. 508–13. [CrossRef] 8. Bojanic N, Bumbasirevic U, Vukovic I, Bojanic G, Milojevic B, Nale D, et al. Testis sparing surgery in the treatment of bilateral testicular germ cell tumors and solitary testicle tumors: A single institution experience. J Surg Oncol 2015
  9. 226–30. [CrossRef] 9. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011
  10. 304–19. [CrossRef] 10. Kabay Ş, İşler B, Sevim M. Testis Sparing Surgery Indications. Bull Urooncol 2015
  11. 235–7. [CrossRef] 11. Göktaş S, Zorba OÜ. Testis tümörlerinde organ koruyucu cerrahi. Uronkoloji Bülteni 2009
  12. 52–8. http://cms.galenos.com.tr/ Uploads/Article_8431/52-58.pdf 12. Shilo Y, Zisman A, Raz O, Lang E, Strauss S, Sandbank J, et al. Testicular sparing surgery for small masses. Urol Oncol 2012
  13. 188–91. [CrossRef] 13. Ates F, Malkoc E, Zor M, Demirer Z, Alp BF, Basal S, et al. TestisSparing surgery in small testicular masses not suspected to be malignant. Clin Genitourin Cancer 2016
  14. e49–53. [CrossRef] 14. Park SB, Lee WC, Kim JK, Choi SH, Kang BS, Moon KH, e